Morgan Stanley’s Alto Ingredients ALTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
354,022
+210,885
+147% +$669K ﹤0.01% 4862
2025
Q4
$412K Buy
143,137
+122,389
+590% +$231K ﹤0.01% 5605
2025
Q3
$22.4K Sell
20,748
-4,837
-19% -$5.44K ﹤0.01% 6658
2025
Q2
$29.4K Sell
25,585
-208,935
-89% -$200K ﹤0.01% 6519
2025
Q1
$267K Buy
234,520
+47,806
+26% +$74K ﹤0.01% 5611
2024
Q4
$291K Buy
186,714
+71,244
+62% +$112K ﹤0.01% 5643
2024
Q3
$186K Buy
115,470
+36,052
+45% +$54.2K ﹤0.01% 5777
2024
Q2
$115K Sell
79,418
-80,010
-50% -$138K ﹤0.01% 5916
2024
Q1
$348K Sell
159,428
-281,836
-64% -$594K ﹤0.01% 5479
2023
Q4
$1.17M Buy
441,264
+241,200
+121% +$768K ﹤0.01% 5227
2023
Q3
$884K Buy
200,064
+42,823
+27% +$165K ﹤0.01% 4869
2023
Q2
$454K Sell
157,241
-423,176
-73% -$806K ﹤0.01% 5262
2023
Q1
$871K Sell
580,417
-27,665
-5% -$75.8K ﹤0.01% 4938
2022
Q4
$1.75M Sell
608,082
-14,901
-2% -$53K ﹤0.01% 4542
2022
Q3
$2.27M Buy
622,983
+318,264
+104% +$1.34M ﹤0.01% 4337
2022
Q2
$1.13M Sell
304,719
-537,656
-64% -$2.81M ﹤0.01% 4939
2022
Q1
$5.75M Buy
842,375
+602,709
+251% +$3.37M ﹤0.01% 3537
2021
Q4
$1.15M Buy
239,666
+82,880
+53% +$435K ﹤0.01% 4966
2021
Q3
$775K Sell
156,786
-248,122
-61% -$1.25M ﹤0.01% 5219
2021
Q2
$2.47M Buy
404,908
+355,112
+713% +$2.07M ﹤0.01% 4470
2021
Q1
$271K Sell
49,796
-1,415
-3% -$9.36K ﹤0.01% 5482
2020
Q4
$278K Sell
51,211
-121,040
-70% -$840K ﹤0.01% 5417
2020
Q3
$1.26M Buy
172,251
+168,471
+4,457% +$584K ﹤0.01% 4043
2020
Q2
$2K Sell
3,780
-53,365
-93% -$26.9K ﹤0.01% 6432
2020
Q1
$15K Buy
57,145
+52,935
+1,257% +$27.8K ﹤0.01% 5902
2019
Q4
$2K Sell
4,210
-215
-5% -$122 ﹤0.01% 6490
2019
Q3
$2K Buy
4,425
+2,656
+150% +$1.72K ﹤0.01% 6465
2019
Q2
$1K Sell
1,769
-1,844
-51% -$1.88K ﹤0.01% 6513
2019
Q1
$3K Sell
3,613
-14,172
-80% -$16.6K ﹤0.01% 6387
2018
Q4
$15K Sell
17,785
-35,642
-67% -$58.9K ﹤0.01% 6075
2018
Q3
$101K Sell
53,427
-132,455
-71% -$296K ﹤0.01% 5682
2018
Q2
$483K Buy
185,882
+63,743
+52% +$203K ﹤0.01% 5123
2018
Q1
$367K Sell
122,139
-24,123
-16% -$96.5K ﹤0.01% 5173
2017
Q4
$665K Buy
146,262
+78,777
+117% +$373K ﹤0.01% 4813
2017
Q3
$374K Sell
67,485
-304,566
-82% -$1.66M ﹤0.01% 5045
2017
Q2
$2.33M Sell
372,051
-31,984
-8% -$208K ﹤0.01% 3671
2017
Q1
$2.77M Buy
404,035
+115,273
+40% +$878K ﹤0.01% 3507
2016
Q4
$2.74M Buy
288,762
+190,170
+193% +$1.53M ﹤0.01% 3630
2016
Q3
$681K Buy
98,592
+74,145
+303% +$478K ﹤0.01% 4314
2016
Q2
$133K Buy
24,447
+16,896
+224% +$83.9K ﹤0.01% 5113
2016
Q1
$35K Buy
7,551
+2,042
+37% +$8.02K ﹤0.01% 5738
2015
Q4
$27K Sell
5,509
-3,308
-38% -$17.3K ﹤0.01% 5937
2015
Q3
$57K Buy
8,817
+3,023
+52% +$23.1K ﹤0.01% 5675
2015
Q2
$60K Sell
5,794
-10,720
-65% -$124K ﹤0.01% 5789
2015
Q1
$178K Sell
16,514
-227,094
-93% -$2.19M ﹤0.01% 5266
2014
Q4
$2.52M Sell
243,608
-275,604
-53% -$3.36M ﹤0.01% 3353
2014
Q3
$7.25M Buy
519,212
+432,184
+497% +$8.13M ﹤0.01% 2313
2014
Q2
$1.33M Sell
87,028
-45,574
-34% -$631K ﹤0.01% 3815
2014
Q1
$2.07M Buy
132,602
+178
+0.1% +$1.8K ﹤0.01% 3386
2013
Q4
$674K Buy
132,424
+121,375
+1,099% +$451K ﹤0.01% 4244
2013
Q3
$38K Buy
11,049
+944
+9% +$3.58K ﹤0.01% 5228
2013
Q2
$41K Buy
+10,105
New +$43.1K ﹤0.01% 5222

Other funds holding ALTO

Morgan Stanley's ALTO Position: Q1 2026 in Review

Morgan Stanley increased its Alto Ingredients (ALTO) stake by 147% in Q1 2026, buying an estimated $669K and bringing the position to 354,022 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #4862.

Morgan Stanley first reported a position in ALTO in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.25M in Q3 2014. 102 funds tracked by Wall St. Rank hold ALTO as of Q1 2026.

  • Morgan Stanley held 354,022 shares of Alto Ingredients worth $1.71M as of Q1 2026.
  • Morgan Stanley bought 210,885 Alto Ingredients shares in Q1 2026, an estimated $669K.
  • Alto Ingredients made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4862 holding.
  • Morgan Stanley first reported a position in Alto Ingredients in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Alto Ingredients position peaked at $7.25M in Q3 2014.
  • 102 funds tracked by Wall St. Rank held Alto Ingredients as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.